Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.14
+0.09 (0.47%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Legend Biotech Revenue

In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth. Legend Biotech had revenue of $306.38M in the quarter ending December 31, 2025, with 64.21% growth.

Revenue (ttm)
$1.03B
Revenue Growth
+64.02%
P/S Ratio
3.44
Revenue / Employee
$347,015
Employees
2,965
Market Cap
3.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 2020 Pro Pro Pro
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ACADIA Pharmaceuticals1.07B
Telix Pharmaceuticals803.79M
Catalyst Pharmaceuticals588.99M
Ligand Pharmaceuticals268.09M
NewAmsterdam Pharma Company22.50M
Crinetics Pharmaceuticals7.70M
Revenue Rankings

LEGN News

More News